21
Views
16
CrossRef citations to date
0
Altmetric
Review Article

Proposals for leflunomide use to avoid lung injury in patients with rheumatoid arthritis

, , , , , , , & show all
Pages 442-446 | Received 07 Dec 2007, Accepted 11 Mar 2008, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Akira Hashiramoto, Kazuko Shiozawa, Yasushi Tanaka, Takashi Yamane, Miki Murata, Chihiro Tanaka, Yasuhiro Terashima, Kozo Koyama, Natsuko Nakagawa, Shuji Abe, Rhosuke Yoshihara, Yasuhiro Saegusa, Ken Tsumiyama, Koichiro Komai, Yoshitada Sakai & Shunichi Shiozawa. (2009) Prospective study of methotrexate treatment for rheumatoid arthritis treated legitimately according to the government recommended 8 mg/week dose. Modern Rheumatology 19:6, pages 637-642.
Read now

Articles from other publishers (13)

KWANGSEOK YANG, MASAKAZU MATSUSHITA & NAOTO TAMURA. (2020) Methotrexate and Oral Antirheumatic Drugs. Juntendo Medical Journal 66:1, pages 27-33.
Crossref
Li-Ta Keng, Mong-Wei Lin, Hsien-Neng Huang & Kuei-Pin Chung. (2016) Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment. Medicine 95:26, pages e4044.
Crossref
Kenjiro FUKUSHIMA, Nozomi EGUCHI, Koichi OHNO, Hideyuki KANEMOTO, Masashi TAKAHASHI, Hirotaka IGARASHI, Aki OHMI, Ko NAKASHIMA & Hajime TSUJIMOTO. (2016) Efficacy of leflunomide for treatment of refractory inflammatory colorectal polyps in 15 Miniature Dachshunds. Journal of Veterinary Medical Science 78:2, pages 265-269.
Crossref
Boulos Haraoui. 2015. Rheumatology. Rheumatology 451 458 .
Glen S. Hazlewood, Pooneh Akhavan, Orit Schieir, Deborah Marshall, George Tomlinson, Vivian Bykerk & Claire Bombardier. (2014) Adding a ?GRADE? to the quality appraisal of rheumatoid arthritis guidelines identifies limitations beyond AGREE-II. Journal of Clinical Epidemiology 67:11, pages 1274-1285.
Crossref
Kazuhiko Nakagawa, Shoji Kudoh, Yuichiro Ohe, Takeshi Johkoh, Masahiko Ando, Naoya Yamazaki, Akihiro Seki, Shinya Takemoto & Masahiro Fukuoka. (2012) Postmarketing Surveillance Study of Erlotinib in Japanese Patients With Non–Small-Cell Lung Cancer (NSCLC): An Interim Analysis of 3488 Patients (POLARSTAR). Journal of Thoracic Oncology 7:8, pages 1296-1303.
Crossref
Tetsuji Sawada. (2011) 5. Leflunomide and Mizoribine.. Nihon Naika Gakkai Zasshi 100:10, pages 2929-2935.
Crossref
J.K. Aronson. 2011. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 815 839 .
T Namba, K-I Tanaka, Y Ito, T Hoshino, M Matoyama, N Yamakawa, Y Isohama, A Azuma & T Mizushima. (2010) Induction of EMT-like phenotypes by an active metabolite of leflunomide and its contribution to pulmonary fibrosis. Cell Death & Differentiation 17:12, pages 1882-1895.
Crossref
Sara A. Colopy, Theresa A. Baker & Peter Muir. (2010) Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006–2008). Journal of the American Veterinary Medical Association 236:3, pages 312-318.
Crossref
Akira Hashiramoto, Kazuko Shiozawa, Yasushi Tanaka, Takashi Yamane, Miki Murata, Chihiro Tanaka, Yasuhiro Terashima, Kozo Koyama, Natsuko Nakagawa, Shuji Abe, Rhosuke Yoshihara, Yasuhiro Saegusa, Ken Tsumiyama, Koichiro Komai, Yoshitada Sakai & Shunichi Shiozawa. (2009) Prospective study of methotrexate treatment for rheumatoid arthritis treated legitimately according to the government recommended 8 mg/week dose. Modern Rheumatology 19:6, pages 637-642.
Crossref
T. Sato, S. Inokuma, A. Sagawa, T. Matsuda, T. Takemura, T. Otsuka, Y. Saeki, T. Takeuchi & T. Sawada. (2009) Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis. Rheumatology 48:10, pages 1265-1268.
Crossref
Kou Katayama & Takeo Matsuno. (2009) Long-term efficacy of leflunomide on disease activity and inhibition of joint damage: retrospective comparison with methotrexate for Japanese rheumatoid arthritis patients. Modern Rheumatology 19:5, pages 513-521.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.